Promotion at Dynavax
30 July 2010

Dr Tyler Martin has been promoted from chief medical officer to the newly created position of president at Dynavax Technologies (US). Dynavax is a clinical-stage biopharmaceutical company, focused on...

Alexza Pharmaceuticals makes board appointment
30 July 2010

Alexza Pharmaceuticals (US) has elected Joseph Turner to its board of directors and as chair of the board's audit and ethics committee. Mr Turner has more than 25 years' experience as a financial...

New appointment at Nile Therapeutics
29 July 2010

Nile Therapeutics, a US-based biopharmaceutical company developing therapeutics for cardiovascular disease, has appointed Richard Brewer executive chairman. Mr Brewer, who has more than 35 years'...

Karen Lackey joins Roche
29 July 2010

Roche has named Karen Lackey vice-president and head of medicinal chemistry. She will be based at the company’s facility in Nutley, New Jersey, and will be responsible for small-molecule drug...

Amgen makes board appointment
29 July 2010

Amgen has appointed Dr Ronald Sugar to its board. Dr Sugar is chairman emeritus of Northrop Grumman and served as the company's chairman and chief executive officer from 2003-09. Before that, he was...

New president for Sanofi-Aventis in Japan
28 July 2010

Jez Moulding will succeed Patrick Chocat as the president of Sanofi-Aventis 's subsidiary in Japan on 1 October. Mr Moulding is currently the general manager of the French group's business in...

Two appointments at Chimerix
22 July 2010

Chimerix, a US biotechnology company developing antiviral therapeutics, has appointed Timothy King vice-president of clinical operations and Dr Hervé Momméja-Marin vice-president of clinical...

Dr Joseph Feczko joins Keryx's board
22 July 2010

Dr Joseph Feczko has joined the board of directors at Keryx Biopharmaceuticals (US). Dr Feczko was, until his retirement in May 2009, senior vice-president and chief medical officer at Pfizer, where...

Seaside Therapeutics makes board appointments
22 July 2010

Seaside Therapeutics (US) has appointed Marc Beer , former CEO of ViaCell, Karen Dawes , president of Knowledge Decisions, and Dr Steven Paul , former executive vice-president for science and...

Spectrum Pharmaceuticals makes appointment
20 July 2010

Spectrum Pharmaceuticals , a US-based biotechnology company with commercial and drug development operations with a focus in haematology and oncology, has appointed Dr George Tidmarsh senior...

New CEO at Nycomed US
20 July 2010

Steve Andrzejewski has been named chief executive officer of Nycomed US . He will be responsible for manufacturing in Melville and Hicksville, New York, distribution and commercial operations for the...

Dr Sarma Duddu joins TARIS Biomedical
20 July 2010

TARIS Biomedical, a US-based speciality pharmaceutical company focused on therapeutics and drug delivery, has named Dr Sarma Duddu president and chief executive officer. He was most recently general...

Board appointment at Delcath
16 July 2010

Delcath Systems (US), a development-stage speciality pharmaceutical and medical device company focused on oncology, has elected Douglas Watson , former president and CEO of Novartis's US subsidiary,...

Ikaria names chief science officer
16 July 2010

The US biotherapeutics company Ikaria has appointed Dr Martin Meglasson chief science officer, effective from the end of this month. Dr Meglasson, who will be responsible for activities related to...

New appointment at Vitae Pharmaceuticals
16 July 2010

Vitae Pharmaceuticals, a US-based development-stage biopharmaceutical company, has named Dr Christine Brennan chief business officer. She has more than 10 years' experience in business development,...